Tuspetinib (HM-43239) is an active pharmaceutical ingredient under investigation in clinical trials for relapsed or refractory acute myeloid leukemia. Its structure features aromatic rings, amines, and a halogen atom, indicating a complex, polar compound.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2569527-64-4
HM43239 monohydrate
pharmaceutical raw material
Sodium sulfapyridazine
pharmaceutical raw material
Zucapsaicin
pharmaceutical raw material
Gemfibrozil
pharmaceutical raw material
FAP-2286?
pharmaceutical raw material
5-chloro-N-[3-cyclopropyl-5-[[(3S,5R)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-amine
FZLSDZZNPXXBBB-KDURUIRLSA-N
C[C@@H]1CN(C[C@@H](N1)C)CC2=CC(=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=C4C=CC(=C5)C)Cl)C6CC6